Home › Craniopharyngioma › District of Columbia
Craniopharyngioma clinical trials in District of Columbia
3 studies for Craniopharyngioma are looking for participants at sites in District of Columbia.
Cities in District of Columbia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
- Children's National Medical Center, Washington D.C.
RecruitingPhase 2
Ages 1 to 39 · All sexes · Updated Apr 23, 2026 · NCT05233397MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
- Children's National Medical Center, Washington D.C.
RecruitingPhase 2
Ages 1 to 39 · All sexes · Updated Apr 8, 2026 · NCT05286788From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.